C&C Vision CrystaLens “Accommodating” IOL Endorsed By FDA Panel

C&C Vision's Model AT-45 CrystaLens likely will be the first intraocular lens (IOL) to reach the U.S. market with lens accommodation as its mechanism of action

More from Archive

More from Medtech Insight